journal
Journals Gastroenterology & Hepatology

Gastroenterology & Hepatology

https://read.qxmd.com/read/39193074/perioperative-risk-in-patients-with-cirrhosis
#21
JOURNAL ARTICLE
Perioperative Risk in Patients With Cirrhosis.
Kay M Johnson
No abstract text is available yet for this article.
39193074
August 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193073/exploring-diets-beyond-the-low-fodmap-diet-to-treat-patients-with-ibs
#22
JOURNAL ARTICLE
Exploring Diets Beyond the Low-FODMAP Diet to Treat Patients With IBS.
Gary R Lichtenstein
No abstract text is available yet for this article.
39193073
August 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206031/update-on-hepatocellular-carcinoma-surveillance-staging-and-therapy
#23
JOURNAL ARTICLE
Update on Hepatocellular Carcinoma Surveillance, Staging, and Therapy.
Sheila Eswaran
No abstract text is available yet for this article.
39206031
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206030/a-case-study-in-the-ibs-c-management-continuum-assessing-patient-response-and-tailoring-treatment
#24
JOURNAL ARTICLE
A Case Study in the IBS-C Management Continuum: Assessing Patient Response and Tailoring Treatment.
Nitin K Ahuja
No abstract text is available yet for this article.
39206030
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206029/positioning-sphingosine-1-phosphate-receptor-modulators-in-inflammatory-bowel-disease
#25
JOURNAL ARTICLE
Positioning Sphingosine-1 Phosphate Receptor Modulators in Inflammatory Bowel Disease.
Bruce E Sands
No abstract text is available yet for this article.
39206029
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206028/exploring-the-use-of-biosimilars-to-treat-patients-with-inflammatory-bowel-disease
#26
JOURNAL ARTICLE
Exploring the Use of Biosimilars to Treat Patients With Inflammatory Bowel Disease.
Gary R Lichtenstein
No abstract text is available yet for this article.
39206028
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206027/clinical-guide-to-navigating-the-landscape-of-biosimilars-for-inflammatory-bowel-disease
#27
JOURNAL ARTICLE
Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel Disease.
Shubha Bhat, Sunanda V Kane
Annual out-of-pocket expenditures for patients with inflammatory bowel disease (IBD) are estimated to be as high as $41,000, with medications, such as biologics, being one of the main cost contributors. Although biologics have revolutionized IBD management, these medications are costly owing to their molecular makeup and manufacturing processes. Biosimilars, which are biologic medications that are highly similar to the US Food and Drug Administration (FDA)-approved reference product with no clinically meaningful differences in safety, purity, or potency, offer the same therapeutic benefits at a reduced cost...
39206027
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206026/adverse-events-associated-with-proton-pump-inhibitors-fact-vs-fiction
#28
JOURNAL ARTICLE
Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction.
Paul Moayyedi
No abstract text is available yet for this article.
39206026
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39206025/current-management-of-patients-with-alcohol-associated-hepatitis
#29
JOURNAL ARTICLE
Current Management of Patients With Alcohol-Associated Hepatitis.
Brian P Lee
No abstract text is available yet for this article.
39206025
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193437/efficacy-of-tenapanor-in-patients-with-ibs-c-a-post-hoc-analysis-of-patients-with-and-without-prior-use-of-other-ibs-c-prescription-medications-from-the-phase-3-t3mpo-1-and-t3mpo-2-studies
#30
JOURNAL ARTICLE
Efficacy of Tenapanor in Patients With IBS-C: A Post Hoc Analysis of Patients With and Without Prior Use of Other IBS-C Prescription Medications From the Phase 3 T3MPO 1 and T3MPO-2 Studies.
(no author information available yet)
No abstract text is available yet for this article.
39193437
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193436/one-size-does-not-fit-all-improving-patient-care-in-ibs-c-an-interview-with-darren-m-brenner-md
#31
JOURNAL ARTICLE
One Size Does NOT Fit All: Improving Patient Care in IBS-C An Interview With Darren M. Brenner, MD.
(no author information available yet)
No abstract text is available yet for this article.
39193436
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193435/efficacy-safety-and-time-to-response-of-linaclotide-in-patients-%C3%A2-65-with-ibs-c
#32
JOURNAL ARTICLE
Efficacy, Safety, and Time to Response of Linaclotide in Patients ≥65 With IBS-C.
(no author information available yet)
No abstract text is available yet for this article.
39193435
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193434/comparing-the-efficacy-of-tenapanor-in-ibs-c-in-hispanic-versus-non-hispanic-patients-a-post-hoc-analysis-of-patients-in-the-phase-3-t3mpo-1-and-t3mpo-2-studies
#33
JOURNAL ARTICLE
Comparing the Efficacy of Tenapanor in IBS-C in Hispanic Versus Non-Hispanic Patients: A Post Hoc Analysis of Patients in the Phase 3 T3MPO-1 and T3MPO-2 Studies.
(no author information available yet)
No abstract text is available yet for this article.
39193434
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193412/upadacitinib-treatment-is-associated-with-improved-clinical-and-quality-of-life-outcomes-in-patients-with-crohn-s-disease-results-from-the-u-endure-long-term-extension
#34
JOURNAL ARTICLE
Upadacitinib Treatment Is Associated With Improved Clinical and Quality of Life Outcomes in Patients With Crohn's Disease: Results From the U-ENDURE Long-Term Extension.
(no author information available yet)
No abstract text is available yet for this article.
39193412
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193411/risankizumab-effectiveness-in-ustekinumab-naive-and-ustekinumab-experienced-patients-with-crohn-s-disease-real-world-data-from-a-large-tertiary-center
#35
JOURNAL ARTICLE
Risankizumab Effectiveness in Ustekinumab-Naive and Ustekinumab-Experienced Patients With Crohn's Disease: Real-World Data From a Large Tertiary Center.
(no author information available yet)
No abstract text is available yet for this article.
39193411
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193410/risankizumab-versus-ustekinumab-for-the-achievement-of-clinical-remission-and-reduction-in-inflammatory-biomarkers-in-patients-with-moderate-to-severe-crohn-s-disease-results-from-the-phase-3b-sequence-trial
#36
JOURNAL ARTICLE
Risankizumab Versus Ustekinumab for the Achievement of Clinical Remission and Reduction in Inflammatory Biomarkers in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 3b SEQUENCE Trial.
(no author information available yet)
No abstract text is available yet for this article.
39193410
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193409/improvement-in-inflammatory-bowel-disease-questionnaire-items-fatigue-depression-anxiety-and-bowel-urgency-in-patients-with-crohn-s-disease-treated-with-upadacitinib-in-phase-3-trials
#37
JOURNAL ARTICLE
Improvement in Inflammatory Bowel Disease Questionnaire Items: Fatigue, Depression, Anxiety, and Bowel Urgency in Patients With Crohn's Disease Treated With Upadacitinib in Phase 3 Trials.
(no author information available yet)
No abstract text is available yet for this article.
39193409
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193408/real-world-clinical-effectiveness-and-safety-of-vedolizumab-and-ustekinumab-in-biologic-naive-patients-with-crohn-s-disease-by-disease-location-results-from-the-evolve-expansion-study
#38
JOURNAL ARTICLE
Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease by Disease Location: Results From the EVOLVE Expansion Study.
(no author information available yet)
No abstract text is available yet for this article.
39193408
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193407/super-responders-in-patients-with-moderate-to-severe-crohn-s-disease-treated-with-subcutaneous-infliximab-maintenance-therapy-a-post-hoc-analysis-of-the-libert-y-cd-study
#39
JOURNAL ARTICLE
Super-Responders in Patients With Moderate-to-Severe Crohn's Disease Treated With Subcutaneous Infliximab Maintenance Therapy: A Post Hoc Analysis of the LIBERT Y-CD Study.
(no author information available yet)
No abstract text is available yet for this article.
39193407
July 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/39193122/effect-of-mirikizumab-on-clinical-and-endoscopic-outcomes-after-1-anti-tnf-failure-in-patients-with-moderately-to-severely-active-ulcerative-colitis
#40
JOURNAL ARTICLE
Effect of Mirikizumab on Clinical and Endoscopic Outcomes After 1 Anti-TNF Failure in Patients With Moderately to Severely Active Ulcerative Colitis.
(no author information available yet)
No abstract text is available yet for this article.
39193122
July 2024: Gastroenterology & Hepatology
next page »
journal
journal
41233
2
3
Make the most of Read.
Download the mobile app.
Fetch more papers »
Fetching more papers... Fetching...

All material on this website is protected by copyright, Copyright © 1994-2024 1994-{new Date().getFullYear()} by WebMD LLC.

By using this service, you agree to our terms of use and privacy policy.

Do Not Sell My Personal Information  Your Privacy Choices

Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

╳

We want to hear from doctors like you!

Take a second to answer a survey question.

╳